|Systematic (IUPAC) name|
aluminum 2-acetyloxybenzoate hydroxide
|CAS Registry Number|
|ATC code||B01 N02|
|Molecular mass||402.288 g/mol|
|(what is this?)|
Aloxiprin (or aluminium acetylsalicylate) is a medical drug used for the treatment of pain and inflammation associated with muscular skeletal and joint disorders. It is used for its properties as an anti-inflammatory, antipyretic and analgesic drug. It is a chemical compound of aluminium hydroxide and aspirin.
Alternative names and combinations
- People with allergies to salicylates.
- People with gastrointestinal ulcers.
- People with liver or kidney damage.
- Pregnant women in the 3rd trimester.
- Women who are breastfeeding.
- Use with other salicylates.
- Use with NSAIDs.
- MIMS. "Aloxiprin". MIMS. Retrieved 16 April 2011.
- Encarta. "Aloxiprin". Encarta. Retrieved 16 April 2011.
- CUMMINGS AJ, MARTIN BK, WIGGINS LF (1963). "In vitro and in vivo properties of aloxiprin: a new aluminium derivative of acetylsalicylic acid". J. Pharm. Pharmacol. 15: 56–62. PMID 14024235.
- Geller J (1968). "A comparative trial of aloxiprin ('Palaprin Forte') and phenylbutazone ('Butazolidin')". The British journal of clinical practice 22 (9): 392–4. PMID 4876729.
- Net Doctor UK. "Askit Powders". Treatments for joint, muscle and bone conditions. Retrieved 16 April 2011.
|This drug article relating to the blood and blood forming organs is a stub. You can help Wikipedia by expanding it.|